HighTower Advisors
GDRX icon

HighTower Advisors’s GoodRx Holdings GDRX Stock Holding History

HighTower Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-153
Closed -$24K – 3248
2021
Q1 		$24K Buy
+153
New +$6.88K ﹤0.01% 2887

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

HighTower Advisors's GDRX Position: Q1 2026 in Review

HighTower Advisors increased its GoodRx Holdings (GDRX) stake by 3.1% in Q1 2026, buying an estimated $4.02K and bringing the position to 57,844 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3615.

HighTower Advisors first reported a position in GDRX in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.67M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • HighTower Advisors held 57,844 shares of GoodRx Holdings worth $113K as of Q1 2026.
  • HighTower Advisors bought 1,715 GoodRx Holdings shares in Q1 2026, an estimated $4.02K.
  • GoodRx Holdings made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3615 holding.
  • HighTower Advisors first reported a position in GoodRx Holdings in Q4 2020 and has held it in 14 quarters since.
  • HighTower Advisors's GoodRx Holdings position peaked at $2.67M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.